Contraception
Volume 82, Issue 5 , Pages 396-403 , November 2010

Non-contraceptive health benefits of intrauterine hormonal systems

  • Ian S. Fraser

      Affiliations

    • Corresponding Author InformationTel.: +61 2 9351 7322; fax: +61 2 9351 4560.

Received 4 May 2010 ,Accepted 4 May 2010.

References 

  1. Pharris BB, Ericksson R, Bashow J, Hoff S, Place VA, Zaffaroni A. Progestasert®, a uterine therapeutic system for long-term contraception: philosophy and clinical efficacy. Fertil Steril. 1974;25:915–921
  2. Luukkainen T. The levonorgestrel-releasing IUD. Br J Fam Plann. 1993;19:221–224
  3. Mansour D. Modern management of abnormal uterine bleeding - the levonorgestrel intrauterine system. Bailliere's Best Prac Res Clin Obstet Gynaecol. 2007;21:1007–1021
  4. Wildemeersch D, Rowe PJ. Assessment of menstrual blood loss in women with idiopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system. Contraception. 2004;70:165–168
  5. Wildemeersch D, Rowe PJ. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system. Contraception. 2005;71:470–473
  6. Sivin I, Stern J, Coutinho E, et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNG 20) and the copper T 380Ag IUDs. Contraception. 1991;44:473–480
  7. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 mcg/day and the copper T Cu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research, Population Council. Fertil Steril. 1994;61:70–77
  8. Mishell DR. jr. Non-contraceptive health benefits of oral steroidal contraceptives. Am J Obstet Gynecol. 1982;142:809–816
  9. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand. 1999;78:716–721
  10. National Institute for Health and Clinical Excellence . Long-acting reversible contraception. Clinical Guideline number 30. London: National Collaborating Centre for Women's and Children's Health; 2005;
  11. Volpe A, Botticelli A, Abrate M, et al. An intrauterine progesterone contraceptive system (52 mg) used in pre- and peri-menopausal patients with endometrial hyperplasia. Maturitas. 1982;4:73–79
  12. Bergqvist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br J Obstet Gynaecol. 1983;90:255–258
  13. New Zealand Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. NZ Med J. 1998;112:174–177
  14. National Institute for Health and Clinical Excellence . Diagnosis and management of heavy menstrual bleeding. London: National Collaborating Centre for Women's and Children's Health; 2007;
  15. Fraser IS, Inceboz US. Defining disturbances of the menstrual cycle. In:  O'Brien PMS,  Cameron IT,  MacLean AM editor. Disorders of the menstrual cycle. London: RCOG Press; 2000;p. 141–152
  16. Woolcock J, Critchley HODC, Munro MG, Broder M, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril. 2008;90:2269–2280[e-pub Oct 2007]
  17. Fraser IS, Critchley HOD, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Hum Reprod. 2007;22:635–643
  18. Fraser IS, Critchley HOD, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87:466–476
  19. Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol. 1990;97:690–694
  20. Chrisman C, Ribiero P, Dalton VK. The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and non-contraceptive uses. Clin Obstet Gynecol. 2007;50:886–897
  21. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;(2):CD003855;Review
  22. Kaunitz AM, Meredith S, Inki P, et al. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2009;113:1104–1116
  23. Higham JM, O'Brien PMS, Shaw RW. Assessemnt of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97:734–739
  24. Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet. 2001;357:273–277
  25. Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia. examination of health episode statistics. BMJ. 2005;330:938–939
  26. Xiao B, Wu SC, Ching J, et al. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril. 2003;79:963–969
  27. Kriplani A, Singh BM, Lal S, Agarwal N. Efficacy, acceptability and side-effects of the levonorgestrel-releasing intrauterine system for menorrhagia. Int J Obstet Gynecol. 2007;97:190–194
  28. Fraser IS. Menstrual confusion. Int J Gynecol Obstet. 2008;100:1–3
  29. Hale GE, Manconi F, Fraser IS. Quantitative menstrual blood loss measurement in ovulatory and anovulatory cycles in mid to late reproductive age and the menopause transition. Obstet Gynecol [in press]
  30. Kadir RA, Chi C. Levonorgestrel-releasing intrauterine system: bleeding disorders and anticoagulant therapy. Contraception. 2007;75:S123–S129
  31. Kingman CE, Kadir RA, Lee CA, et al. The use of the levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. Br J Obstet Gynaecol. 2004;111:1425–1428
  32. Schaedel ZE, Dolan G, Powell MC. The use of levonorgestrel-releasing intrauterine system in the management of women with hemostatic disorders. Am J Obstet Gynecol. 2005;193:1361–1363
  33. Lukes AS, Reardon B, Arepally G. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders. Fertil Steril. 2008;90:673–677
  34. Vilos GA, Tureanu V, Garcia M, Basim AR. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy. J Min Invas Gynecol. 2009;16:480–484
  35. Kaunitz AM. Progestin-releasing intrauterine systems and leiomyoma. Contraception. 2007;75:S130–S133
  36. Mercorio F, DeSimone R, Di Spiezio Sardo A, et al. The effect of a levonorgestrel-releasing intrauterine system in the treatment of myoma-related menorrhagia. Contraception. 2003;67:277–280
  37. Grigorieva V, Chen-Mok M, Tarasova M, et al. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to intrauterine leiomyomas. Fertil Steril. 2003;79:1194–1198
  38. Soysal S, Soysal ME. The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia. Gynecol Obstet Invest. 2005;5:29–35
  39. Magalhaes J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception. 2007;75:193–198
  40. Fedele L, Bianchi S, Raffaelli R, et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril. 1997;68:426–429
  41. Bragheto AM, Caserta N, Bahamondes L, Petta CA. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception. 2007;76:195–199
  42. Cho S, Nam H, Kim D, et al. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol. 2008;198:373–377
  43. Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception. 1999;60:173–175
  44. Imperato F, Perniola G, Mossa B, et al. The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status. Minerva Gynecol. 2002;54:271–278
  45. Lilhong A. Investigation on the prevalence and influencing factors to anaemia in women of reproductive age. China J Epidemiol. 1999;20:158–161
  46. Varma R, Soneja H, Bhatia K, et al. The effectiveness of a levonorgestrel-releasing intrauterine system in the treatment of endometrial hyperplasia - a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol. 2008;139:169–175
  47. Orbo A, Arnes M, Hancke C, et al. Treatment results of endometrial hyperplasia after prospective D-score classification. A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008;111:68–73
  48. Orbo A, Rise CE, Mutter G. Regression of latent endometrial precancers by progestin infiltrated intrauterine device. Cancer Res. 2006;66:5613–5617
  49. Bahamondes L, Ribeiro-Huguet P, de Andrade K, Leomartins O, Petta CA. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand. 2003;82:580–582
  50. Dhar-Kalyan K, Needhirajan T, Koslowski M, Woolas RP. Is the levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol. 2005;97:924–927
  51. Vercellini P, Aimi G, Panazza S, et al. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril. 1999;72:505–508
  52. Petta CA, Ferriani RA, Abrao M, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod. 2005;20:1993–1998
  53. Bahamondes L, Petta CA, Fernandes A, Monteiro I. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception. 2007;75(Suppl 6):S134–S139
  54. Vercellini P, Frontino G, De Giorgio G, et al. Comparison of a levonorgestrel-releasing intrauterine system versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305–309
  55. Fraser IS. The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease. Contraception. 2007;75:S112–S117
  56. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science. 1993;259:633–638
  57. Toivonen J, Luukkainen T, Allonen H, et al. Protective effects of intrauterine release of levonorgestrel on pelvic infection. Three years of comparative experience of levonorgestrel and copper-releasing intrauterine devices. Obstet Gynecol. 1991;77:261–264
  58. Bagwell MA, Thompson SJ, Addy CL, et al. Primary infertility and oral contraceptive steroid use. Fertil Steril. 1995;63:1161–1166
  59. Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol. 1982;17:529–536
  60. Hurskainen R, Salmi A, Paavonen J, Teperi J, Rutanen E. Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel. Mol Hum Reprod. 2000;6:1013–1018
  61. Hidalgo MM, Hidalgo-Regina C, Bahamondes V, et al. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel releasing intrauterine system. Contraception. 2009;80:84–89
  62. Maruo T, Laoag-Fernandez JB, Pakarinen P, et al. Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod. 2001;16:2103–2108
  63. Short RV. The evolution of human reproduction. Proc Roy Soc Lond B. 1976;195:3–24
  64. Eaton SB, Pike MC, Short RV, et al. Women's reproductive cancers in evolutionary context. Quart Rev Biol. 1994;69:353–367

PII: S0010-7824(10)00322-7

doi: 10.1016/j.contraception.2010.05.005

Contraception
Volume 82, Issue 5 , Pages 396-403 , November 2010

Article Tools